Yixintang Pharmaceutical Group Co Ltd
SZSE:002727
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
11.09
26.22
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Yixintang Pharmaceutical Group Co Ltd
Yixintang Pharmaceutical Group Co Ltd
Interest Income Expense
Yixintang Pharmaceutical Group Co Ltd
Interest Income Expense Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Yixintang Pharmaceutical Group Co Ltd
SZSE:002727
|
Interest Income Expense
-¥82.7m
|
CAGR 3-Years
-134%
|
CAGR 5-Years
-54%
|
CAGR 10-Years
-23%
|
|
|
D
|
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
|
Interest Income Expense
-¥195.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-68%
|
CAGR 10-Years
N/A
|
|
|
LBX Pharmacy Chain JSC
SSE:603883
|
Interest Income Expense
-¥113.5m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
N/A
|
|
|
Yifeng Pharmacy Chain Co Ltd
SSE:603939
|
Interest Income Expense
-¥57.9m
|
CAGR 3-Years
-47%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
N/A
|
|
|
ShuYu Civilian Pharmacy Corp Ltd
SZSE:301017
|
Interest Income Expense
-¥101m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
A
|
Anhui Huaren Health Pharmaceutical Co Ltd
SZSE:301408
|
Interest Income Expense
-¥14.1m
|
CAGR 3-Years
-57%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Yixintang Pharmaceutical Group Co Ltd
Glance View
Yixintang Pharmaceutical Group Co., Ltd. engages in the pharmaceutical retail chain and pharmaceutical wholesale business. The company is headquartered in Kunming, Yunnan and currently employs 32,503 full-time employees. The company went IPO on 2014-07-02. The Company’s main products include traditional Chinese medicines, western medicines, medical equipment, birth control products and disinfection products, among others. The firm distributes its products through regular chain drugstores. The firm mainly operates its business in domestic market, with southwest area of China as its main market.
See Also
What is Yixintang Pharmaceutical Group Co Ltd's Interest Income Expense?
Interest Income Expense
-82.7m
CNY
Based on the financial report for Jun 30, 2024, Yixintang Pharmaceutical Group Co Ltd's Interest Income Expense amounts to -82.7m CNY.
What is Yixintang Pharmaceutical Group Co Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
-23%
Over the last year, the Interest Income Expense growth was -9%. The average annual Interest Income Expense growth rates for Yixintang Pharmaceutical Group Co Ltd have been -134% over the past three years , -54% over the past five years , and -23% over the past ten years .
You don't have any saved screeners yet
